Page last updated: 2024-10-20

trimethylamine and Intracranial Arteriosclerosis

trimethylamine has been researched along with Intracranial Arteriosclerosis in 1 studies

Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spector, R1

Reviews

1 review available for trimethylamine and Intracranial Arteriosclerosis

ArticleYear
New Insight into the Dietary Cause of Atherosclerosis: Implications for Pharmacology.
    The Journal of pharmacology and experimental therapeutics, 2016, Volume: 358, Issue:1

    Topics: Animals; Cholesterol; Coronary Artery Disease; Diet; Diet, Vegetarian; Humans; Hydroxymethylglutaryl

2016